Benzinga · Sep 22, 2026
HC Wainwright & Co. Downgrades HeartBeam to Neutral
HC Wainwright & Co. analyst Yi Chen downgrades HeartBeam (NASDAQ:BEAT) from Buy to Neutral.
NASDAQ · BEAT
HeartBeam, Inc.
Healthcare · Medical - Healthcare Information Services
$0.54
Down-$0.04 (-7.02%)
Updated Oct 8, 2026, 8:10 AM
SID Score
3.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 73.04M
- P/E ratio
- -3.54
- Dividend yield
- 0.00%
- 52-week range
- $0.36 – $4.00
- Volume
- 5.11M
- Avg. volume
- 6.54M
Price performance · BEAT
BEAT price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 7, 2026
BEAT closed at $0.54 after 21 trading sessions, up 29.50% for the selected period.
- Last close
- $0.54
- Period change
- +29.50%
- Period low
- $0.36
- Period high
- $0.65
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 7, 2026 | $0.588 | $0.615 | $0.5301 | $0.543 | 5.11M |
| Oct 6, 2026 | $0.6226 | $0.64 | $0.57 | $0.584 | 18.32M |
| Oct 5, 2026 | $0.75 | $0.95 | $0.60 | $0.6542 | 404.24M |
| Oct 2, 2026 | $0.43 | $0.454 | $0.4218 | $0.4346 | 804.19K |
| Oct 1, 2026 | $0.368 | $0.4476 | $0.3652 | $0.419 | 1.79M |
| Sep 30, 2026 | $0.3682 | $0.3839 | $0.3584 | $0.3666 | 153.66K |
| Sep 29, 2026 | $0.385 | $0.385 | $0.3638 | $0.3679 | 286.99K |
| Sep 28, 2026 | $0.36 | $0.3816 | $0.36 | $0.373 | 485K |
| Sep 25, 2026 | $0.379 | $0.379 | $0.355 | $0.3598 | 684.44K |
| Sep 24, 2026 | $0.39 | $0.40 | $0.3612 | $0.379 | 683.4K |
| Sep 23, 2026 | $0.42 | $0.4257 | $0.3888 | $0.3889 | 599.2K |
| Sep 22, 2026 | $0.44 | $0.45 | $0.43 | $0.4337 | 522.73K |
| Sep 21, 2026 | $0.40 | $0.4334 | $0.40 | $0.431 | 357.71K |
| Sep 18, 2026 | $0.43 | $0.43 | $0.4021 | $0.4029 | 288.01K |
| Sep 17, 2026 | $0.41 | $0.424 | $0.4088 | $0.4197 | 137.91K |
| Sep 16, 2026 | $0.4141 | $0.4175 | $0.4016 | $0.4094 | 319.14K |
| Sep 15, 2026 | $0.405 | $0.44 | $0.40 | $0.425 | 1.03M |
| Sep 14, 2026 | $0.4011 | $0.4156 | $0.40 | $0.4058 | 237.35K |
| Sep 11, 2026 | $0.42 | $0.4207 | $0.39 | $0.4064 | 275.83K |
| Sep 10, 2026 | $0.415 | $0.425 | $0.405 | $0.4104 | 246.24K |
| Sep 9, 2026 | $0.44 | $0.46 | $0.4176 | $0.4193 | 351.62K |
Latest BEAT news
The latest Smart Investors Daily articles mentioning BEAT.
Stock researchCompany · Overview
Company
Market Activity
Research & News
BEAT research
Overview
Company profile and research snapshot.
Company profile
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $5.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 22, 2026 | HC Wainwright & Co. | Neutral | — |
| Jul 14, 2026 | Maxim Group | Buy | — |
| May 22, 2026 | HC Wainwright & Co. | Buy | — |
| May 15, 2026 | Benchmark | Speculative Buy | — |
| Mar 31, 2026 | B. Riley Securities | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 14, 2026
HeartBeam Enters ATM Equity Offering Agreement To Sell Up To $25M Of Common Stock Through Titan Partners Securities
On August 14, 2026, HeartBeam, Inc. (the "Company"), entered into an At-The-Market Equity Offering Sales Agreement (the "Sales Agreement") with Titan Partners Securities LLC, as sales agent, pursuant to
Benzinga · Aug 13, 2026
HeartBeam Reports Q2 2026 Results: Full Earnings Call Transcript
HeartBeam (NASDAQ:BEAT) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and financial
SeekingAlpha · Aug 13, 2026
HeartBeam, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-13. The following slide deck was published by HeartBeam, Inc.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
